Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ETR vs GSK✓SelectedUSD · GSKETR vs GSK performance historyLatest closeAs of+0.40%11/18
Stock and ETF performance explorer

ETR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+17.1%
GSK return
+7.0%
Excess return
+10.2%
Maximum drawdown
-15.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.4%-1.3%+1.7%+0.6%
7D-3.0%-3.1%+0.2%-2.4%
30D+4.7%-0.9%+5.6%+4.8%
3M+0.5%-4.2%+4.7%+1.3%
6M-0.2%-1.6%+1.3%0.0%
YTD+19.7%+2.6%+17.1%+18.6%
1Y+17.1%+6.2%+10.9%+15.4%
All+17.1%+7.0%+10.2%+15.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling